Test Tube Alchemy: Venture capitalists hope to concoct portfolio winners out of life-sciences stocks that have taken their lumpsByStaff Writer1 January 1999•6 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsManagers